Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression

Nature Genetics

Volumn 21, Issue 1, 1999, Pages 133-137

  Wang, Jianming ^a   Wilhelmsson, Hans ^a   Graff, Caroline ^a   Li, Hong ^a   Oldfors, Anders ^b   Rustin, Pierre ^c   Brüning, Jens C ^d   Kahn, C Ronald ^d   Clayton, David A ^e   Barsh, Gregory S ^f   Thorén, Peter ^g   Larsson, Nils Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; ATRIOVENTRICULAR BLOCK; GENE EXPRESSION; HEART DILATATION; KEARNS SAYRE SYNDROME; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOMYOPATHY, DILATED; CREATINE KINASE; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GENE EXPRESSION REGULATION; HEART; HEART BLOCK; HIGH MOBILITY GROUP PROTEINS; HUMANS; INTEGRASES; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; NAD(P)H DEHYDROGENASE (QUINONE); NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRAL PROTEINS; XENOPUS PROTEINS;

ANIMALIA; EUKARYOTA;

EID: 0032924872     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5089     Document Type: Article

References (30)

1. Larsson, N.G. & Clayton, D.A. Molecular genetic aspects of human mitochondrial disorders. Annu. Rev. Genet. 29, 151-178 (1995).
2. Schon, E.A., Hirano, M. & DiMauro, S. Mitochondrial encephalomyopathies: clinical and molecular analysis. J. Bioenerg. Biomembr. 26, 291-299 (1995).
3. Munnich, A. et al. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur. J. Pediatr. 155, 262-274 (1996).
4. Lightowlers, R.N., Chinnery, P.F., Turnbull, D.M. & Howell, N. Mammalian mitothondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 13, 450-455 (1997).
5. Wallace, D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628-632 (1992).
6. Clayton, D.A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell Biol. 7, 453-478 (1991).
7. Parisi, M.A. & Clayton, D.A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 252, 965-969 (1991).
8. Larsson, N.G. et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nature Genet. 18, 231-236(1998).
9. Lyons, G. E. et al. Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle. Development 113, 1017-1029 (1991).
10. Trask, R.V. & Biltadello, J.J. Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim. Biophys. Acta 1049, 182-188 (1990).
11. Grove, D., Zak, R., Nair, K.G. & Aschenbrenner, V. Biochemical correlates of cardiac hypertrophy IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ. Res. 25, 473-485 (1969).
12. Zak, R. Development and proliferative capacity of cardiac muscle cells. Circ. Res. 35, (suppl. II). 17-26 (1974).
13. Moore, G.W., Hutchins, G.M., Bulkley, B.H., Tseng, J.S. & Ki, P.F. Constituents of the human ventricular myocardium: connective tissue hyperplasia accompanying muscular hypertrophy. Am. Heart J. 100, 610-616 (1980).
14. Li, Y.B. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11, 376-381 (1995).
15. Graham, B.H. et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nudeotide translocator. Nature Genet. 16, 226-234 (1997).
16. Hayashi, J.-I. et al. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl Acad Sci. USA 88, 10614-10618 (1991).
17. Shoubridge, E.A., Karpati, G. & Hastings, K.E.M. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 62, 43-49 (1990).
18. Moraes, C.T. et al. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nature Genet. 1, 359-367 (1992).
19. Oldfors, A. et al. Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J. Neurol. Sci. 110, 169-177 (1992).
20. Connor, M.K., Takahashi, M & Hood, D.A. Tissue-specific stability of nuclear-and mitochondrially encoded mRNAs. Arch. Biochem. Biophys. 333, 103-108 (1996).
21. Larsson, N.G., Holme, E., Kristiansson, B., Oldfors, A. & Tulinius, M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr. Res. 28, 131-136 (1990).
22. (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am. J. Hum. Genet. 51, 1201-1212 (1992).
23. Weber, K. et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am. J. Hum. Genet. 60, 373-380 (1997).
24. Müller-Höcker, J. et al. In situ hybridization of mitochondrial DNA in the heart of a patient with Kearns-Sayre syndrome and dilatative cardiomyopathy. Hum. Pathol. 23, 1431-1437 (1992).
25. Berenberg, R.A. et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann. Neurol. 1, 37-54 (1977).
26. Rustin, P. et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228, 35-51 (1994).
27. Hakulinen, T. & Tenkanen, L. Regression analysis of relative survival rates. Appl. Stat. 36, 309-317 (1987).
28. Axenborg, J.E. & Hirsch, I. A PC-based on-line system for physiological in vivo and in vitro experiments. Comput. Methods Programs Biomed. 41, 55-67 (1993).
29. Hoit, B.D., Khoury, S.F., Kranias, E.G., Ball, N. & Walsh, R.A. In vivo echocardiographic detection of enhanced left ventricular function in genetargeted mice with phospholamban deficiency. Circ. Res. 77, 632-637 (1995).
30. Johansson, C. & Thoren, P. The effects of triiodothyronine (T3) on heart rate, temperature and ECG measured with telemetry in freely moving mice. Acta Physiol. Scand. 160, 133-138 (1997).